The European Commission has pulled marketing authorisations for generic versions of Biogen’s oral multiple sclerosis therapy Tecfidera, after concluding that the brand qualifies for additional ...

Tecfidera (dimethyl fumarate) is a brand-name oral capsule that’s prescribed for certain types of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Tecfidera has interactions with ...

For example, the PBMs marked up the price of dimethyl fumarate, a multiple sclerosis treatment known by the brand name Tecfidera, by more than 2,000% in commercial health plans and by more than ...

Shares in Biogen are on the rise after the company successfully defended its blockbuster multiple sclerosis drug Tecfidera from a patent challenge brought by Mylan in the US. The Patent Trial and ...